Hereditary Transthyretin-mediated Amyloidosis With Polyneropathy

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Hereditary Transthyretin-mediated Amyloidosis With Polyneropathy trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

Not Yet RecruitingNot Applicable

NCT04270058

TEGSEDI Pregnancy Surveillance Program

This is a worldwide safety surveillance study of pregnancy outcomes in women with hATTR-PN who may have been exposed or were not exposed to TEGSEDI prior to or…

Location not specified20 participantsStarted 2025-12

Treatment: inotersen